Meghan Markle and Kyle Richards both plugged La Roche-Posay’s Toleriane Hydrating Gentle Cleanser this month — and while the product’s already pretty affordable, you can snag it for even less during ...

L'Oréal recalls La Roche-Posay Effaclar Duo in the U.S. due to benzene concerns. Learn about affected products and consumer ...

Keep reading to learn what makes French skincare so premium to other systems, and how French Pharmacy brings the finest ...

Ready to give your skincare routine a glow-up—for free? La Roche-Posay is offering a free sample of its beloved 10% Pure Vitamin C Serum, and it’s as easy as signing up while supplies last. If you’ve ...

The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.

34,796 people played the daily Crossword recently. Can you solve it faster than others?34,796 people played the daily Crossword recently. Can you solve it faster than others?

Roche is currently enacting a “fundamental reorganisation” of its gene therapy subsidiary Spark Therapeutics amid broader shifts in its pharmaceuticals business. The move, first revealed in the ...

Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the hyper-competitive market for obesity drugs. Morten Lammert will join Roche as its ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in ...

Only one point separates Barcelona, Real Madrid and Atlético Madrid in the La Liga standings after 27 games. La Liga is home to the closest title race across Europe's top five leagues.

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it over to a new center in Harvard’s Enterprise Research Campus.